Download Slide ()

yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Randomized clinical trial to assess the value of breast-conserving therapy in stage I and stage II breast cancer (EORTC Trial 10801). Kaplan-Meier curves
for (A) overall survival, (B) distant metastases-free survival, (C) locoregional recurrence-free survival in patients with a diagnosis of clinical stage I or II
invasive carcinoma of the breast treated with either breast-conserving therapy (BCT) plus breast radiotherapy or with mastectomy. (N, number of patients;
O, observed.) [Reproduced with permission, from Van Dongen JA, Voogd AC, Fentiman IS, et al. Long-term results of a randomized trial comparing
breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst.
Source: Chapter 45. The EORTC Experience: From DCIS to Locally Advanced Breast Cancer, Kuerer's Breast Surgical Oncology
Citation: Kuerer HM. Kuerer's Breast Surgical Oncology; 2010 Available at: Accessed: May 02, 2017
Copyright © 2017 McGraw-Hill Education. All rights reserved